Northern Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Northern Trust’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-882,259	Closed	-$47.6M	–	4310
2017 Q4	$47.6M	Sell	882,259 -62,246	-7%	-$3.41M	0.01%	1013
2017 Q3	$53.9M	Sell	944,505 -35,602	-4%	-$2.09M	0.01%	902
2017 Q2	$59M	Buy	980,107 +17,147	+2%	+$976K	0.02%	807
2017 Q1	$52.4M	Buy	+962,960	New	+$47.4M	0.02%	888

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Northern Trust's BIVV Position: Q1 2018 in Review

Northern Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 882,259 shares — an estimated $47.6M sold.

Northern Trust first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $59M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Northern Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Northern Trust sold 882,259 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $47.6M.
Northern Trust first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Northern Trust's Bioverativ Inc. Common Stock position peaked at $59M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Northern Trust's 13F filing for Q1 2018, filed 9 May 2018.